232 related articles for article (PubMed ID: 16143410)
1. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
Malone DT; Taylor DA
Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M
Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196
[TBL] [Abstract][Full Text] [Related]
3. Repeated but not acute treatment with ∆⁹-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D₂/₃ receptor antagonist haloperidol.
Tournier BB; Ginovart N
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1415-23. PubMed ID: 24846537
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
[TBL] [Abstract][Full Text] [Related]
5. The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice.
Sakaue M; Ago Y; Baba A; Matsuda T
Psychopharmacology (Berl); 2003 Oct; 170(1):73-9. PubMed ID: 12768276
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.
Ballmaier M; Bortolato M; Rizzetti C; Zoli M; Gessa G; Heinz A; Spano P
Neuropsychopharmacology; 2007 Oct; 32(10):2098-107. PubMed ID: 17299506
[TBL] [Abstract][Full Text] [Related]
7. The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice.
Malone DT; Long LE; Taylor DA
Pharmacol Biochem Behav; 2004 Apr; 77(4):839-45. PubMed ID: 15099930
[TBL] [Abstract][Full Text] [Related]
8. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
Mansbach RS; Rovetti CC; Winston EN; Lowe JA
Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
[TBL] [Abstract][Full Text] [Related]
9. Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.
Zamberletti E; Piscitelli F; Cadeddu F; Rubino T; Fratta W; Fadda P; Di Marzo V; Parolaro D
Br J Pharmacol; 2012 Dec; 167(8):1652-64. PubMed ID: 22762735
[TBL] [Abstract][Full Text] [Related]
10. Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol.
Burne TH; Alexander S; Turner KM; Eyles DW; McGrath JJ
Behav Pharmacol; 2014 Jun; 25(3):236-44. PubMed ID: 24776491
[TBL] [Abstract][Full Text] [Related]
11. Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood.
Abela AR; Rahbarnia A; Wood S; Lê AD; Fletcher PJ
Psychopharmacology (Berl); 2019 Jun; 236(6):1875-1886. PubMed ID: 30694374
[TBL] [Abstract][Full Text] [Related]
12. Different pharmaceutical preparations of Δ
Rohleder C; Pahlisch F; Graf R; Endepols H; Leweke FM
Addict Biol; 2020 May; 25(3):e12745. PubMed ID: 30938471
[TBL] [Abstract][Full Text] [Related]
13. HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits.
Roberts BZ; Minassian A; Halberstadt AL; He YV; Chatha M; Geyer MA; Grant I; Young JW
Int J Neuropsychopharmacol; 2021 Nov; 24(11):894-906. PubMed ID: 34338765
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
McMahon LR; France CP
Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
[TBL] [Abstract][Full Text] [Related]
15. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
16. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
17. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
18. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine.
Bakshi VP; Swerdlow NR; Braff DL; Geyer MA
Biol Psychiatry; 1998 Mar; 43(6):436-45. PubMed ID: 9532349
[TBL] [Abstract][Full Text] [Related]
19. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
20. Effects of REM sleep deprivation on sensorimotor gating and startle habituation in rats: role of social isolation in early development.
Chang HA; Liu YP; Tung CS; Chang CC; Tzeng NS; Huang SY
Neurosci Lett; 2014 Jul; 575():63-7. PubMed ID: 24861517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
